How much do antiretroviral drugs penetrate into the central nervous system?

Por Ene, L, Duiculescu, D, Ruta, SM
Publicado em 2011

Major HIV resistance mutations in untreated Romanian patients

Por Temereanca, A, Ene, L, Duiculescu, D, Ruta, S
Publicado em 2011

Hepatitis B virus compartmentalization in the cerebrospinal fluid of HIV-infected patients

Por Ene, L., Duiculescu, D., Tardei, G., Ruta, S., Smith, D. M., Mehta, S., Letendre, S., Achim, C. L.
Publicado no Clin Microbiol Infect (2014)

Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection

Por Ene, L, Marcotte, TD, Umlauf, A, Grancea, C, Temereanca, A, Bharti, A, Achim, CL, Letendre, S, Ruta, SM
Publicado no J Neuroimmunol (2016)

Plasma Levels of Glucose and Insulin in Patients with Brain Tumors

Por ALEXANDRU, OANA, ENE, L., PURCARU, OANA STEFANA, TACHE, DANIELA ELISE, POPESCU, ALISA, NEAMTU, OANA MARIA, TATARANU, LIGIA GABRIELA, GEORGESCU, ADA MARIA, TUDORICA, VALERICA, ZAHARIA, CORNELIA, DRICU, ANICA
Publicado em 2014

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings

Por Revell, A. D., Wang, D., Wood, R., Morrow, C., Tempelman, H., Hamers, R. L., Alvarez-Uria, G., Streinu-Cercel, A., Ene, L., Wensing, A. M. J., DeWolf, F., Nelson, M., Montaner, J. S., Lane, H. C., Larder, B. A.
Publicado em 2013